MoonLake Immunotherapeutics (MLTX)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch MLTX
Latest sale
$22k
Jul 27 · Routine
Form 4 sales
27
On record
Form 144 notices
13
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

19
Routine
0
Plan not stated
1
No plan
7
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. Jul 27, 2026Routine

    Reich Kristian, Chief Scientific Officer, sold under 0.1% of their holdings

    $22k1,100 shares at $20.00

    Filed Jul 29, 2026Form 4

  2. Jul 22, 2026Routine

    Reich Kristian, Chief Scientific Officer, sold 1.9% of their holdings

    $1M52,448 shares at $20.02

    Filed Jul 23, 2026Form 4

  3. Jul 20, 2026Routine

    Reich Kristian, Chief Scientific Officer, sold 1.6% of their holdings

    $878k43,700 shares at $20.09

    Filed Jul 21, 2026Form 4

  4. Jul 15, 2026Routine

    Reich Kristian, Chief Scientific Officer, sold 0.6% of their holdings

    $322k16,105 shares at $20.01

    Filed Jul 20, 2026Form 4

  5. Jul 15, 2026Notice

    Reich Kristian, Chief Scientific Officer, filed a notice to sell 150,000 shares

    $2.9M150,000 shares

    Filed Jul 15, 2026Form 144

  6. Jul 10, 2026Routine

    Santos da Silva Jorge, Chief Executive Officer, sold 3.6% of their holdings

    $2M102,225 shares at $20.02

    Filed Jul 13, 2026Form 4

  7. Jul 1, 2026Routine

    Santos da Silva Jorge, Chief Executive Officer, sold 1.6% of their holdings

    $957k47,775 shares at $20.03

    Filed Jul 2, 2026Form 4

  8. Jun 30, 2026Notice

    Santos da Silva Jorge, Chief Executive Officer, filed a notice to sell 150,000 shares

    $3M150,000 shares

    Filed Jun 30, 2026Form 144

  9. Jun 22, 2026Routine

    Bodenstedt Matthias, Chief Financial Officer, sold 3.4% of their holdings

    $862k39,120 shares at $22.04

    Filed Jun 23, 2026Form 4

  10. Jun 18, 2026Routine

    Bodenstedt Matthias, Chief Financial Officer, sold 1.5% of their holdings

    $352k17,876 shares at $19.67

    Filed Jun 18, 2026Form 4

10 of 40

Every transaction

Every transaction on a Form 4 or Form 5 for MLTX
TradedFiledStockNameRoleWhatAmountPriceValueHeld afterSource
Jul 27, 2026Jul 29, 2026MLTXReich KristianChief Scientific OfficerSold1,100$20.00$22k2.7MSEC
Jul 22, 2026Jul 23, 2026MLTXReich KristianChief Scientific OfficerSold52,448$20.02$1M2.7MSEC
Jul 20, 2026Jul 21, 2026MLTXReich KristianChief Scientific OfficerSold43,700$20.09$878k2.8MSEC
Jul 15, 2026Jul 20, 2026MLTXReich KristianChief Scientific OfficerSold16,105$20.01$322k2.8MSEC
Jul 10, 2026Jul 13, 2026MLTXSantos da Silva JorgeChief Executive OfficerSold102,225$20.02$2M2.8MSEC
Jul 1, 2026Jul 2, 2026MLTXSantos da Silva JorgeChief Executive OfficerSold47,775$20.03$957k2.9MSEC
Jun 22, 2026Jun 23, 2026MLTXBodenstedt MatthiasChief Financial OfficerSold39,120$22.04$862k1.1MSEC
Jun 18, 2026Jun 18, 2026MLTXBodenstedt MatthiasChief Financial OfficerSold17,876$19.67$352k1.2MSEC
Jun 17, 2026Jun 18, 2026MLTXPhillips Andrew JohnDirectorAwardedOption to Buy22,19522,195SEC
Jun 17, 2026Jun 18, 2026MLTXLoy SpikeDirectorAwardedOption to Buy22,19522,195SEC
Jun 17, 2026Jun 18, 2026MLTXMoukheibir CatherineDirectorAwardedOption to Buy22,19522,195SEC
Jun 17, 2026Jun 18, 2026MLTXXavier RamnikDirectorAwardedOption to Buy22,19522,195SEC
Jun 17, 2026Jun 17, 2026MLTXReich KristianChief Scientific OfficerSold150,000$19.01$2.9M2.8MSEC
Jun 17, 2026Jun 22, 2026MLTXBVF Partners OS Ltd.DirectorAwardedOption to Buy22,19522,195SEC
May 11, 2026May 13, 2026MLTXBodenstedt MatthiasChief Financial OfficerSold13,653$20.02$273k1.2MSEC
Apr 14, 2026Apr 16, 2026MLTXBodenstedt MatthiasChief Financial OfficerSold2,426$19.56$47k1.2MSEC
Apr 13, 2026Apr 14, 2026MLTXSantos da Silva JorgeChief Executive OfficerSold150,000$18.35$2.8M2.9MSEC
Apr 10, 2026Apr 10, 2026MLTXBodenstedt MatthiasChief Financial OfficerSold87,795$18.95$1.7M1.2MSEC
Mar 31, 2026Apr 2, 2026MLTXLampert Mark NDirector, 10% ownerSold3.8M$16.79$63M1MSEC
Jan 7, 2026Jan 9, 2026MLTXBodenstedt MatthiasChief Financial OfficerAwarded354,2961.3MSEC
Jan 7, 2026Jan 9, 2026MLTXSantos da Silva JorgeChief Executive OfficerAwardedStock Option (Right to Buy)520,342520,342SEC
Jan 7, 2026Jan 9, 2026MLTXReich KristianChief Scientific OfficerAwardedStock Option (Right to Buy)520,342520,342SEC
Dec 19, 2025Dec 22, 2025MLTXBodenstedt MatthiasChief Financial OfficerReturned to the company294,4730SEC
Dec 19, 2025Dec 22, 2025MLTXBodenstedt MatthiasChief Financial OfficerConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG8,7540SEC
Dec 19, 2025Dec 22, 2025MLTXBodenstedt MatthiasChief Financial OfficerConverted294,473922,009SEC
Dec 19, 2025Dec 22, 2025MLTXReich KristianChief Scientific OfficerReturned to the company35,3890SEC
Dec 19, 2025Dec 22, 2025MLTXReich KristianChief Scientific OfficerConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG1,0520SEC
Dec 19, 2025Dec 22, 2025MLTXReich KristianChief Scientific OfficerConverted35,38935,389SEC
Dec 19, 2025Dec 22, 2025MLTXSantos da Silva JorgeChief Executive OfficerReturned to the company196,3160SEC
Dec 19, 2025Dec 22, 2025MLTXSantos da Silva JorgeChief Executive OfficerConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG5,8360SEC
Dec 19, 2025Dec 22, 2025MLTXSantos da Silva JorgeChief Executive OfficerConverted196,3163.1MSEC
Dec 9, 2025Dec 10, 2025MLTXSantos da Silva JorgeChief Executive OfficerSold200,000$14.87$3M2.9MSEC
Dec 9, 2025Dec 10, 2025MLTXReich KristianChief Scientific OfficerSold202,908$14.85$3M0SEC
Oct 8, 2025Oct 9, 2025MLTXBodenstedt MatthiasChief Financial OfficerBought10,870$9.09$99k627,536SEC
Sep 30, 2025Oct 1, 2025MLTXCormorant Global Healthcare Master Fund, LPOtherSold6.5M$7.21$46.9M2MSEC
Sep 2, 2025Sep 4, 2025MLTXReich KristianChief Scientific OfficerReturned to the company48,97835,389SEC
Sep 2, 2025Sep 4, 2025MLTXReich KristianChief Scientific OfficerConverted48,978202,908SEC
Jul 3, 2025Jul 7, 2025MLTXMoukheibir CatherineDirectorSold23,500$48.79$1.1M0SEC
Jul 3, 2025Jul 7, 2025MLTXMoukheibir CatherineDirectorExercised or settledOption to Buy23,50021,500SEC
Jul 3, 2025Jul 7, 2025MLTXMoukheibir CatherineDirectorExercised options23,50023,500SEC
Jun 5, 2025Jun 9, 2025MLTXSturge SimonDirectorAwardedOption to Buy6,6826,682SEC
Jun 5, 2025Jun 9, 2025MLTXLoy SpikeDirectorAwardedOption to Buy6,6826,682SEC
Jun 5, 2025Jun 9, 2025MLTXXavier RamnikDirectorAwardedOption to Buy6,6826,682SEC
Jun 5, 2025Jun 9, 2025MLTXMoukheibir CatherineDirectorAwardedOption to Buy6,6826,682SEC
Jun 5, 2025Jun 9, 2025MLTXPhillips Andrew JohnDirectorAwardedOption to Buy6,6826,682SEC
Jun 5, 2025Jun 9, 2025MLTXBvf INC/ilDirector, 10% ownerAwardedOption to Buy6,6826,682SEC
Feb 27, 2025Mar 3, 2025MLTXSantos da Silva JorgeChief Executive OfficerAwarded95,7633.1MSEC
Feb 27, 2025Mar 3, 2025MLTXReich KristianChief Scientific OfficerAwardedStock Option (Right to Buy)139,273139,273SEC
Feb 27, 2025Mar 3, 2025MLTXBodenstedt MatthiasChief Financial OfficerAwarded95,763616,666SEC
Jan 20, 2025Sep 4, 2025MLTXReich KristianChief Scientific OfficerConvertedCommon shares, par value CHF 0.10 per share, of MoonLake AG1,4561,052SEC
Page 1

Sales, notices and lockups (40)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for MLTX
Source
Jul 27, 2026Jul 29, 2026Reich KristianMLTXChief Scientific OfficerForm 4 sale1,100$22k0.0%RoutineSEC
Jul 22, 2026Jul 23, 2026Reich KristianMLTXChief Scientific OfficerForm 4 sale52,448$1M1.9%RoutineSEC
Jul 20, 2026Jul 21, 2026Reich KristianMLTXChief Scientific OfficerForm 4 sale43,700$878k1.6%RoutineSEC
Jul 15, 2026Jul 20, 2026Reich KristianMLTXChief Scientific OfficerForm 4 sale16,105$322k0.6%RoutineSEC
Jul 15, 2026Jul 15, 2026Reich KristianMLTXChief Scientific OfficerForm 144 notice150,000$2.9MNoticeSEC
Jul 10, 2026Jul 13, 2026Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale102,225$2M3.6%RoutineSEC
Jul 1, 2026Jul 2, 2026Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale47,775$957k1.6%RoutineSEC
Jun 30, 2026Jun 30, 2026Santos da Silva JorgeMLTXChief Executive OfficerForm 144 notice150,000$3MNoticeSEC
Jun 22, 2026Jun 23, 2026Bodenstedt MatthiasMLTXChief Financial OfficerForm 4 sale39,120$862k3.4%RoutineSEC
Jun 18, 2026Jun 18, 2026Bodenstedt MatthiasMLTXChief Financial OfficerForm 4 sale17,876$352k1.5%RoutineSEC
Jun 17, 2026Jun 17, 2026Reich KristianMLTXChief Scientific OfficerForm 4 sale150,000$2.9M5.0%RoutineSEC
Jun 15, 2026Jun 15, 2026Reich KristianMLTXChief Scientific OfficerForm 144 notice150,000$2.9MNoticeSEC
May 11, 2026May 13, 2026Bodenstedt MatthiasMLTXChief Financial OfficerForm 4 sale13,653$273k1.2%RoutineSEC
Apr 14, 2026Apr 16, 2026Bodenstedt MatthiasMLTXChief Financial OfficerForm 4 sale2,426$47k0.2%RoutineSEC
Apr 13, 2026Apr 14, 2026Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale150,000$2.8M4.9%No planSEC
Apr 10, 2026Apr 10, 2026Bodenstedt MatthiasMLTXChief Financial OfficerForm 4 sale87,795$1.7M6.9%RoutineSEC
Apr 10, 2026Apr 10, 2026Santos da Silva JorgeMLTXChief Executive OfficerForm 144 notice150,000$2.8MNoticeSEC
Apr 9, 2026Apr 9, 2026Bodenstedt MatthiasMLTXChief Financial OfficerForm 144 notice160,870$3MNoticeSEC
Mar 31, 2026Apr 2, 2026Lampert Mark NMLTXDirector, 10% ownerForm 4 sale3.8M$63M78.3%UnusualSEC
Mar 31, 2026Mar 31, 2026Bvf Partners L P/ilMLTX10% Stockholder, Affiliate of DirectorForm 144 notice3.8M$63.5MNoticeSEC
Dec 9, 2025Dec 10, 2025Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale200,000$3M6.5%UnusualSEC
Dec 9, 2025Dec 10, 2025Reich KristianMLTXChief Scientific OfficerForm 4 sale202,908$3M100.0%UnusualSEC
Dec 8, 2025Dec 8, 2025Santos da Silva JorgeMLTXChief Executive OfficerForm 144 notice200,000$3MNoticeSEC
Dec 8, 2025Dec 8, 2025Reich KristianMLTXChief Scientific OfficerForm 144 notice202,908$3MNoticeSEC
Sep 30, 2025Oct 1, 2025Cormorant Global Healthcare Master Fund, LPMLTXOtherForm 4 sale6.5M$46.9M76.5%UnusualSEC
Jul 3, 2025Jul 7, 2025Moukheibir CatherineMLTXDirectorForm 4 sale23,500$1.1M100.0%UnusualSEC
Jul 3, 2025Jul 3, 2025Moukheibir CatherineMLTXDirectorForm 144 notice23,500$1.1MNoticeSEC
Oct 4, 2024Oct 8, 2024Sturge SimonMLTXDirectorForm 4 sale171,000$9.2M49.9%UnusualSEC
Oct 4, 2024Oct 8, 2024Bvf I Gp LLCMLTXDirector, 10% ownerForm 4 sale2M$100M60.8%UnusualSEC
Feb 29, 2024Feb 29, 2024Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale123,615$6.8M4.0%RoutineSEC
Feb 28, 2024Feb 29, 2024Reich KristianMLTXChief Scientific OfficerForm 4 sale118,922$6.5M3.9%RoutineSEC
Feb 21, 2024Feb 23, 2024Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale1,125$62k0.0%RoutineSEC
Feb 21, 2024Feb 22, 2024Reich KristianMLTXChief Scientific OfficerForm 4 sale21,078$1.2M0.7%RoutineSEC
Feb 20, 2024Feb 20, 2024Santos da Silva JorgeMLTXChief Executive OfficerForm 4 sale60,000$3.6M1.9%RoutineSEC
Feb 16, 2024Feb 16, 2024Reich KristianMLTXChief Scientific OfficerForm 4 sale60,000$3.7M2.0%RoutineSEC
Feb 15, 2024Feb 15, 2024Santos da Silva JorgeMLTXChief Executive OfficerForm 144 notice200,000$12.8MNoticeSEC
Feb 14, 2024Feb 14, 2024Reich KristianMLTXChief Scientific OfficerForm 144 notice200,000$12.6MNoticeSEC
Dec 20, 2023Dec 21, 2023Bodenstedt MatthiasMLTXChief Financial OfficerForm 4 sale100,000$5.9M16.1%RoutineSEC
Dec 20, 2023Dec 20, 2023Bodenstedt MatthiasMLTXChief Financial OfficerForm 144 notice5,264$312kNoticeSEC
Dec 19, 2023Dec 19, 2023Bodenstedt MatthiasMLTXChief Financial OfficerForm 144 notice94,736$5.6MNoticeSEC